Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115700643 | 11570064 | 3 | F | 20160706 | 20150929 | 20160720 | PER | US-PFIZER INC-2015126427 | PFIZER | 68.00 | YR | F | Y | 52.00000 | KG | 20160720 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
115700643 | 11570064 | 1 | PS | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | UNK | 19949 | ||||||||||
115700643 | 11570064 | 2 | SS | VFEND | VORICONAZOLE | 1 | Oral | 200 MG, 2X/DAY | E1044243 | 21266 | 200 | MG | FILM-COATED TABLET | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
115700643 | 11570064 | 1 | Coccidioidomycosis |
115700643 | 11570064 | 2 | Coccidioidomycosis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
115700643 | 11570064 | Constipation | |
115700643 | 11570064 | Drug ineffective for unapproved indication | |
115700643 | 11570064 | Functional gastrointestinal disorder | |
115700643 | 11570064 | Rash generalised | |
115700643 | 11570064 | Rectal tenesmus | |
115700643 | 11570064 | Skin exfoliation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
115700643 | 11570064 | 2 | 20150401 | 20150601 | 0 |